INmune Bio Inc. Common stock (INMB) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for INMB were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001711754 (2026-04-11) ↗